# US 2016/0355533 A1 · Crystalline Fosaprepitant Dicyclohexylamine Salt And Its Preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355533 A1
- Document ID: US20160355533A1
- Status: Published application
- Kind: A1
- Application number: 15/165,643
- Filed: 2016-05-26
- Published: 2016-12-08
- Earliest claimed: 2015-06-03
- Assignees: Navinta LLC
- Inventors: Jigneshkumar Jasubhai Patel; Raja Jeyakumar John Muthiah
- Web page: https://patentgrep.com/patent/US20160355533A1

## CPC

- C07F 9/65583: {each of the hetero rings containing nitrogen as ring hetero atom}
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61P 1/08: for nausea, cinetosis or vertigo; Antiemetics
- C07C 211/35: containing only non-condensed rings
- C07F 9/65586: {at least one of the hetero rings does not contain nitrogen as ring hetero atom}
- C07C 2601/14: The ring being saturated
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention provides dicyclohexylamine salt of fosaprepitant (fosaprepitant DCHA), a process for preparing fosaprepitant DCHA, and a use of fosaprepitant DCHA in the preparation of pharmaceutically acceptable fosaprepitant dimeglumine with high purity. Fosaprepitant dimeglumine is prepared by treating fosaprepitant DCHA with an acid to form fosaprepitant, followed by adding N-methyl-D-glucamine to fosaprepitant.

## Claims

### Claim 1

A fosaprepitant di(dicyclohexylamine) salt of formula II:

### Claim 2 (depends on 1)

The fosaprepitant di(dicyclohexylamine) salt of claim 1, wherein the fosaprepitant di(dicyclohexylamine) salt has a purity level of greater than about 99.0% as measured by HPLC.

### Claim 3 (depends on 1)

The fosaprepitant di(dicyclohexylamine) salt of claim 1, wherein the fosaprepitant di(dicyclohexylamine) salt is in a crystalline form.

### Claim 4 (depends on 3)

The fosaprepitant di(dicyclohexylamine) salt of claim 3 having an X-ray powder diffraction pattern with peaks at about 4.52, 8.29, 13.17, 17.23, 18.31, and 22.51±0.2°2θ.

### Claim 5 (depends on 3)

The fosaprepitant di(dicyclohexylamine) salt of claim 3 having Fourier transform IR spectra showing absorptions at about 1061, 1133, 1170, 1281, 1450, 1509, 1678, 2525, 2858, 2937, and 3395 cm−1.

### Claim 6

A process for preparing a fosaprepitant di(dicylohexylamine) salt of formula II comprising:
(1) hydrogenating a dibenzyl fosaprepitant of formula IV in the presence of a mixture comprising 10% Pd/C, dicyclohexylamine, and a solvent system to form the fosaprepitant di(dicylohexylamine) salt of formula and
(2) isolating the fosaprepitant di(dicylohexylamine) salt of formula II.

### Claim 7 (depends on 6)

The process of claim 6, wherein step (1) is carried out at a temperature in the range from about 15° C. to about 50° C. for about 1 to about 12 hours.

### Claim 8 (depends on 6)

The process of claim 6, wherein the mixture in step (1) further comprises basic alumina.

### Claim 9 (depends on 6)

The process of claim 6, wherein the solvent system is a mixture of an organic solvent and water; wherein the organic solvent is selected from the group consisting of ethyl acetate, methyl-tert-butyl ether, methanol, isopropanol, and a mixture thereof.

### Claim 10 (depends on 9)

The process of claim 9, wherein the organic solvent is methanol.

### Claim 11 (depends on 6)

The process of claim 6, wherein step (2) comprises the steps of:
(3) filtering the reaction mixture to obtain a filtrate solution; and
(4) concentrating the filtrate solution to obtain the fosaprepitant di(dicylohexylamine) salt in a solid form.

### Claim 12 (depends on 11)

The process of claim 11, wherein step (2) further comprises crystallization, and optionally recrystallization, of the fosaprepitant di(dicylohexylamine) salt of formula II.

### Claim 13 (depends on 12)

The process of claim 12, wherein the crystallization, and optionally recrystallization, of the fosaprepitant di(dicylohexylamine) salt of formula II, is carried out by using a solvent selected from a group consisting of acetone, ethyl acetate, acetonitrile, methyl ethyl ketone, and a mixture thereof.

### Claim 14 (depends on 6)

The process of claim 6, further comprising:
preparing the dibenzyl fosaprepitant of formula IV by reacting aprepitant of formula III with tetrabenzyl pyrophosphate in the presence of a base and a solvent.

### Claim 15

A process for the preparation of fosaprepitant di(N-methyl-D-glucamine) salt of formula Ia:
comprising:
(1) treating a solution of fosaprepitant di(dicyclohexylamine) salt of formula II with an acid to obtain fosaprepitant of formula I;
(2) dissolving fosaprepitant of formula I and N-methyl-D-glucamine in a solvent to obtain a solution of fosaprepitant di(N-methyl-D-glucamine) salt of formula Ia; and
(3) isolating fosaprepitant di(N-methyl-D-glucamine) salt of formula Ia.

### Claim 16 (depends on 15)

The process according to claim 15, wherein the solvent is selected from a group consisting of methanol, ethanol, isopropyl alcohol, and a mixture thereof.

### Claim 17 (depends on 15)

The process according to claim 15, wherein the step of isolating fosaprepitant di(N-methyl-D-glucamine) salt of formula Ia is carried out by adding a second solvent.

### Claim 18 (depends on 17)

The process according to claim 17, wherein the second solvent is selected from a group consisting of ethanol, isopropyl alcohol, acetonitrile, acetone, ethyl acetate, isopropyl acetate, methyl ethyl ketone, and a mixture thereof.

### Claim 19 (depends on 15)

Fosaprepitant dimeglumine of formula Ia prepared by the process of claim 15.

### Claim 20 (depends on 19)

The fosaprepitant dimeglumine of claim 19, wherein the fosaprepitant dimeglumine has a purity level of greater than about 99.0% as measured by HPLC.
